Delta 8 times less sensitive to vax antibodies- The New Indi

Delta 8 times less sensitive to vax antibodies- The New Indian Express


Delta 8 times less sensitive to vaccine antibodies
Study among hospital staff, including those from Sir Ganga Ram, says inoculated people should not lower their guard
Share Via Email
  |  A+A A-
The new study says severe disease in fully vaccinated HCWs is rare but breakthrough infection is a concern and Covid-control measures need to continue
By Express News Service
NEW DELHI: The Delta variant of novel coronavirus is eight times less sensitive to antibodies generated by vaccines as compared to the original strain that came from China’s Wuhan, according to a new study.The study, which was conducted on more than 100 healthcare workers (HCWs) at three centres in India including Sir Ganga Ram Hospital (SGRH), found that the B.1.617.2 Delta variant not only dominates vaccine-breakthrough infections with higher respiratory viral loads compared to non-Delta infections but also generates greater transmission among the fully vaccinated HCWs. The collaborative study, “Sars-Cov-2 B.1.617.2 Delta Variant Emergence and Vaccine Breakthrough: Collaborative Study”, from India with scientists from Cambridge Institute of Therapeutic Immunology and Infectious Disease is yet to be peer-reviewed.

Related Keywords

Cambridge , Cambridgeshire , United Kingdom , India , Wuhan , Hubei , China , Chand Wattal , Institute Of Clinical Microbiology , Cambridge Institute Of Therapeutic Immunology , News Service , Express News , Sir Ganga Ram Hospital , Variant Emergence , Vaccine Breakthrough , Cambridge Institute , Therapeutic Immunology , Infectious Disease , Clinical Microbiology , கேம்பிரிட்ஜ் , கேம்பிரிட்ஜ்ஷைர் , ஒன்றுபட்டது கிஂக்டம் , இந்தியா , சீனா , மந்திரம் வாட்டல் , நிறுவனம் ஆஃப் மருத்துவ நுண்ணுயிரியல் , கேம்பிரிட்ஜ் நிறுவனம் ஆஃப் சிகிச்சை நோயெதிர்ப்பு , செய்தி சேவை , எக்ஸ்பிரஸ் செய்தி , ஐயா கங்கா ரேம் மருத்துவமனை , தடுப்பூசி திருப்புமுனை , கேம்பிரிட்ஜ் நிறுவனம் , சிகிச்சை நோயெதிர்ப்பு , தொற்று நோய் , மருத்துவ நுண்ணுயிரியல் ,

© 2025 Vimarsana